Page last updated: 2024-08-26

moexipril and Metabolic Syndrome

moexipril has been researched along with Metabolic Syndrome in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ivleva, AIa; Kolesnikova, AV; Minina, ES; Moskvicheva, IuB; Poluianova, NV	1
Belousov, IuB; Demidova, MA; Leonova, MV; Tarasov, AV	2

Trials

1 trial(s) available for moexipril and Metabolic Syndrome

Article	Year
[Assessment of antihypertensive efficacy of moexipril in metabolic syndrome]. Kardiologiia, 2005, Volume: 45, Issue:12 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure Determination; Body Mass Index; Cholesterol; Data Interpretation, Statistical; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Risk Factors; Sphygmomanometers; Tetrahydroisoquinolines; Time Factors; Treatment Outcome	2005

Article

Year

[Assessment of antihypertensive efficacy of moexipril in metabolic syndrome].

Kardiologiia, 2005, Volume: 45, Issue:12

Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure Determination; Body Mass Index; Cholesterol; Data Interpretation, Statistical; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Risk Factors; Sphygmomanometers; Tetrahydroisoquinolines; Time Factors; Treatment Outcome

2005

Other Studies

2 other study(ies) available for moexipril and Metabolic Syndrome

Article	Year
[Comparative efficacy and safety of contemporary Angiotensin converting enzyme inhibitors moexipril and spirapril in women with postmenopausal metabolic syndrome]. Kardiologiia, 2006, Volume: 46, Issue:1 Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Humans; Hypertension; Lipids; Metabolic Syndrome; Middle Aged; Postmenopause; Tetrahydroisoquinolines; Treatment Outcome	2006
[Hypotensive, organoprotective, and metabolic effects of Angiotensin converting enzyme inhibitor moexipril in women with postmenopausal syndrome]. Kardiologiia, 2006, Volume: 46, Issue:5 Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Delayed-Action Preparations; Diuretics; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension; Lipids; Metabolic Syndrome; Middle Aged; Postmenopause; Syndrome; Tetrahydroisoquinolines; Treatment Outcome; Vasodilation	2006

Article

Year

[Comparative efficacy and safety of contemporary Angiotensin converting enzyme inhibitors moexipril and spirapril in women with postmenopausal metabolic syndrome].

Kardiologiia, 2006, Volume: 46, Issue:1

Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Humans; Hypertension; Lipids; Metabolic Syndrome; Middle Aged; Postmenopause; Tetrahydroisoquinolines; Treatment Outcome

2006

[Hypotensive, organoprotective, and metabolic effects of Angiotensin converting enzyme inhibitor moexipril in women with postmenopausal syndrome].

Kardiologiia, 2006, Volume: 46, Issue:5

Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Delayed-Action Preparations; Diuretics; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension; Lipids; Metabolic Syndrome; Middle Aged; Postmenopause; Syndrome; Tetrahydroisoquinolines; Treatment Outcome; Vasodilation

2006